{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:58:25Z","timestamp":1781661505266,"version":"3.54.5"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.josat.2023.209213","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T20:10:49Z","timestamp":1700251849000},"page":"209213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Changes in buprenorphine waivered provider supply after Virginia Medicaid implements the addiction and recovery treatment services program and Medicaid expansion"],"prefix":"10.1016","volume":"157","author":[{"given":"Atika Farzana","family":"Urmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Britton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Harrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chethan","family":"Bachireddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2023.209213_bb0005","author":"Center for Disease Control and Prevention"},{"key":"10.1016\/j.josat.2023.209213_bb0010","unstructured":"Centers for Medicare & Medicaid Services. Health expenditures by state of residence, 1991\u20132020 (n.d.). Retrieved June 14, 2022, from https:\/\/www.cms.gov\/research-statistics-data-and-systems\/statistics-trends-and-reports\/nationalhealthexpenddata\/nationalhealthaccountsstatehealthaccountsresidence."},{"key":"10.1016\/j.josat.2023.209213_bb0015","author":"Cunningham"},{"key":"10.1016\/j.josat.2023.209213_bb0020","author":"Cunningham"},{"key":"10.1016\/j.josat.2023.209213_bb0025","author":"Cunningham"},{"key":"10.1016\/j.josat.2023.209213_bb0030","unstructured":"DMAS - Department of Medical Assistance Services. Addiction and recovery treatment services. (n.d.). Retrieved July 23, 2022, from https:\/\/www.dmas.virginia.gov\/for-providers\/addiction-and-recovery-treatment-services."},{"key":"10.1016\/j.josat.2023.209213_bb0035","unstructured":"Dsgonline.com. Buprenorphine prescribers newsletter. (n.d.). Retrieved June 23, 2023, from https:\/\/www.dsgonline.com\/DataWaiver\/enews\/2017\/2017_11_28\/dw_enews_web.html."},{"issue":"8","key":"10.1016\/j.josat.2023.209213_bb0040","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","article-title":"National and state treatment need and capacity for opioid agonist medication-assisted treatment","volume":"105","author":"Jones","year":"2015","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.josat.2023.209213_bb0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jsat.2018.07.008","article-title":"Comparison between buprenorphine provider availability and opioid deaths among US counties","volume":"93","author":"Jones","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.josat.2023.209213_bb0050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/08897077.2019.1635959","article-title":"Adoption of the 275-patient buprenorphine treatment waiver for treating opioid use disorder: A state-level longitudinal analysis","volume":"41","author":"Knudsen","year":"2020","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2023.209213_bb0055","series-title":"Medications for opioid use disorder save lives","author":"Leshner","year":"2019"},{"issue":"11","key":"10.1016\/j.josat.2023.209213_bb0060","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s11606-019-05165-6","article-title":"Association between the number of certified buprenorphine prescribers and the quantity of buprenorphine prescriptions: Evidence from 2015 to 2017","volume":"34","author":"Lin","year":"2019","journal-title":"Journal of General Internal Medicine"},{"issue":"6","key":"10.1016\/j.josat.2023.209213_bb0065","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1176\/appi.ps.202000491","article-title":"Changes in buprenorphine treatment after Medicaid expansion","volume":"72","author":"Olfson","year":"2021","journal-title":"Psychiatric Services (Washington, D.C.)"},{"key":"10.1016\/j.josat.2023.209213_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108513","article-title":"Medicaid participation among practitioners authorized to prescribe buprenorphine","volume":"133","author":"Saunders","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209213_bb0075","author":"Substance Abuse and Mental Health Service Administration (SAMHSA)"},{"key":"10.1016\/j.josat.2023.209213_bb0080","author":"The Henry J. Kaiser Family Foundation"},{"key":"10.1016\/j.josat.2023.209213_bb0085","author":"Urban Institute"},{"issue":"4","key":"10.1016\/j.josat.2023.209213_bb0090","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/MLR.0000000000000703","article-title":"Impact of Medicaid expansion on Medicaid-covered utilization of buprenorphine for opioid use disorder treatment","volume":"55","author":"Wen","year":"2017","journal-title":"Medical Care"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:50:30Z","timestamp":1757433030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923002643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":18,"alternative-id":["S2949875923002643"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209213","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in buprenorphine waivered provider supply after Virginia Medicaid implements the addiction and recovery treatment services program and Medicaid expansion","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209213","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209213"}}